It is largest vertically integrated pharma company in the country and the company is engaged in the manufacturing business of pharmaceutical formulations, formulation ingredients and organic intermediates. The products manufactured by the company covers wide range like antibiotics,anti-retrovirals,anti -diabetics, CVS,CNS, Gastro-enterologicals and Anti Allergicals.In order to produce the wide ranged products and its intermediates and supplying them to the consuming centres, the company has 14 manufacturing plants across the world conforming to GMO/ISO regulations and well equipped R&D facility.Aurobindo Pharma has identified international operations very well and exports its products to nearly 100 countries across the world.
The market capitalisation of the company is Rs.5084.43 crores having PE ratio 8.56. The current market price of the scrip is Rs.174.65 as on 22.07.2011.
It is one of the companies which are edium and long term bets for investment..The financials for the last 4 years are as given below:
EPS of the company is Rs.20.40, Current ratio is 1.21, netprofit margin is 14.33% and return on long term funds is 23.31% as on 31.03.2011.
The growth of the company is slightly erratic, but with recent exclusive marketing arrangement with Pfizer, the company will post steady growth in coming years.
Aurobindo Pharma is one of the top 5 manufacturers of semi-synthetic pencillin in the world.Recently the company has signed a licensing and supply agreement with Pfizer to supply dosages and sterile products.Pfizer has acquired rights from the company to sell 75 drug as pills and 12 injectables in US and European Market.
| Figures in rs crores | FY 2011 | FY2010 | FY2009 | FY2008 |
| Income | 4284.83 | 3511.76 | 2630.28 | 2421.13 |
| Net Profit | 593.80 | 525.76 | 128.54 | 290.78 |
| Reserves & Surplus | 2540.50 | 1886.50 | 1293.95 | 1193.72 |
| Debt | 2317.72 | 1944.78 | 2144.68 | 1755.65 |
| Share capital | 29.11 | 27.86 | 26.88 | 26.88 |
In June 2011,HDFC top 200 fund, equity funds, prudence funds , Birla Mutual fund , SBI Magnum, Kotak mutual funds have invested substantial amounts in Aurobindo Pharma. 21.526.099 shares of the company have been purchased by mutual funds in June 2011.In addition to the above mutual have acquired shares earlier also showing confidence in the future growth of the company.
The great thing about this post is quality information. I always like to read amazingly useful and quality content. Your article is amazing, thank you for sharing this article.
ReplyDeleteBannari Amman Sugars Limited
Bansal Roofing Products Limited
Banswara Syntex Limited
Barak Valley Cements Limited